3.4.23.49 2-aminobenzoyl-A-(L)R-(D)R-A-3-[(2,4-dinitrophenyl)amino]-L-alanyl-Gly - 54268 3.4.23.49 Al3+ 1 mM, 47% residual activity 264 3.4.23.49 amprenavir - 1608 3.4.23.49 Aprotinin classical protease inhibitors are ineffective against CroP activity, but the serine protease inhibitor aprotinin displays inhibitory potency in the micromolar range. Aprotinin acts as a competitive inhibitor of CroP activity and interferes with the cleavage of the murine cathelicidin-related antimicrobial peptide. Structural model of the aprotinin-omptin complex in which Lys15 of aprotinin forms salt bridges with conserved negatively charged residues of the omptin active site, molecular docking, overview. Aprotinin inhibits CRAMP proteolytic degradation by CroP. Docking model of the aprotinin-omptin complex. Lys15 of aprotinin interacts with Glu27 and Asp208 (OmpT numbering), which are the two negatively charged residues that form the S1 specificity pocket of omptins 405 3.4.23.49 Aprotinin ability of EHEC EDL933 cells to cleave the FRET substrate in the presence of increasing concentrations of aprotinin, about 90% inhibition at 0.2 mM. Docking model of the aprotinin-omptin complex. Lys15 of aprotinin interacts with Glu27 and Asp208 (OmpT numbering), which are the two negatively charged residues that form the S1 specificity pocket of omptin 405 3.4.23.49 Aprotinin inhibits CroP in a competitive manner 405 3.4.23.49 Aprotinin inhibits OmpT in a competitive manner 405 3.4.23.49 arginine - 532 3.4.23.49 atazanavir sulfate - 239975 3.4.23.49 benzamidine - 579 3.4.23.49 calf thymus histone H2B growth inhibitory activity against bacterial gene expressing Escherichia coli with calculated 50% growth inhibitory concentrations of 3.8 microM. Histone H2B penetrates the cell membrane of JCM5491 OmpT+ cells 86661 3.4.23.49 calf thymus histone H3 growth inhibitory activity against bacterial gene expressing Escherichia coli with calculated 50% growth inhibitory concentrations of 10 microM. Histones H3 and H4 remain on the cell surface and subsequently disrupt the cell membrane structure with bleb formation in a manner similar to general antimicrobial peptides 86662 3.4.23.49 calf thymus histone H4 growth inhibitory activity against bacterial gene expressing Escherichia coli with calculated 50% growth inhibitory concentrations of 12.7 microM. Histones H3 and H4 remain on the cell surface and subsequently disrupt the cell membrane structure with bleb formation in a manner similar to general antimicrobial peptides 86663 3.4.23.49 Co2+ - 23 3.4.23.49 Cu2+ - 19 3.4.23.49 Cu2+ CuCl2 19 3.4.23.49 Cu2+ 1 mM, 77% residual activity 19 3.4.23.49 Cu2+ enzyme binding study 19 3.4.23.49 CuCl2 significant inhibition at 1 mM 347 3.4.23.49 darunavir - 1901 3.4.23.49 diisopropyl fluorophosphates - 11341 3.4.23.49 diisopropylfluorophosphate - 299 3.4.23.49 diisopropylfluorophosphate significant inhibition only at high concentrations 299 3.4.23.49 Fe2+ - 25 3.4.23.49 fosamprenavir - 167956 3.4.23.49 guanidine hydrochloride 50 mM, 40% residual activity 1048 3.4.23.49 indinavir - 1036 3.4.23.49 lipopolysaccharide i.e. LPS, rough, dependent on, interacts with the beta-barrel in the outer membrane, function and mechanism overview, smooth LPS sterically inhibits the enzyme via its O-side chain 890 3.4.23.49 Mg2+ enzyme binding study 6 3.4.23.49 additional information not: EDTA, phenylmethylsulfonyl fluoride 2 3.4.23.49 additional information molecular docking study with protease inhibitors, overview. No interaction with lopinavir and tipranavir 2 3.4.23.49 NaCl optimal activity in absence of NaCl, 80% inhibition by 0.15 M NaCl 42 3.4.23.49 nelfinavir - 1193 3.4.23.49 pepstatin - 396 3.4.23.49 pepstatin A 5 mM, complete loss of activity 309 3.4.23.49 phenylmethylsulfonyl fluoride - 257 3.4.23.49 phenylmethylsulfonyl fluoride poor inhibitor, only at high concentrations 257 3.4.23.49 ritonavir - 996 3.4.23.49 saquinavir - 997 3.4.23.49 SDS 0.02%, complete loss of activity 124 3.4.23.49 tosyl-L-phenylalanine chloromethyl ketone - 9281 3.4.23.49 Tween 20 up to 1%, 80% residual activity 555 3.4.23.49 Urea 50 mM, 72% residual activity 116 3.4.23.49 Zn - 932 3.4.23.49 Zn2+ - 14 3.4.23.49 Zn2+ uncompetitive, pH-dependent; ZnCl2 14 3.4.23.49 Zn2+ ZnCl2 14 3.4.23.49 Zn2+ enzyme binding study 14 3.4.23.49 ZnCl2 significant inhibition at 1 mM 271